Sonia Rajesh Schneider, MD | |
986155 Nebraska Medical Ctr, Omaha, NE 68198-6155 | |
(402) 559-3964 | |
Not Available |
Full Name | Sonia Rajesh Schneider |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 986155 Nebraska Medical Ctr, Omaha, Nebraska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316439094 | NPI | - | NPPES |
Entity Name | Unmc Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
NJIT Professor Gordon Thomas and NJIT Research Professor Reginald Farrow, both in the department of physics, and NJIT alumnus Sheng Liu, formerly a doctoral student of both researchers and now an engineer at a biotech company, were awarded a patent today for the NJIT SmartShunt-, a unique device to help patients with brain injuries.
Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the publication of a clinical validation study on the MaterniT GENOME laboratory-developed test in the American Journal of Obstetrics and Gynecology.
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.
Today, Polyphor Ltd published the discovery of a new class of antibiotics with a novel mode of action (Science, VOL 327, ISSUE 5968). This proprietary new class of antibiotics is effective against multi-drug resistant Gram-negative bacteria, opening up new treatment options for serious and often life-threatening infections. The most advanced drug candidate in this new class, POL7080, selectively kills the dangerous bacteria Pseudomonas aeruginosa.
A dynamic new assessment for helping victims of trauma to the brain, including those suffering from progressive conditions such as dementia, has been developed by a clinical neuropsychologist at the University of Leicester.
› Verified 5 days ago
Entity Name | Madonna Rehabilitation Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417045642 PECOS PAC ID: 0446164081 Enrollment ID: O20031118000079 |
News Archive
NJIT Professor Gordon Thomas and NJIT Research Professor Reginald Farrow, both in the department of physics, and NJIT alumnus Sheng Liu, formerly a doctoral student of both researchers and now an engineer at a biotech company, were awarded a patent today for the NJIT SmartShunt-, a unique device to help patients with brain injuries.
Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the publication of a clinical validation study on the MaterniT GENOME laboratory-developed test in the American Journal of Obstetrics and Gynecology.
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.
Today, Polyphor Ltd published the discovery of a new class of antibiotics with a novel mode of action (Science, VOL 327, ISSUE 5968). This proprietary new class of antibiotics is effective against multi-drug resistant Gram-negative bacteria, opening up new treatment options for serious and often life-threatening infections. The most advanced drug candidate in this new class, POL7080, selectively kills the dangerous bacteria Pseudomonas aeruginosa.
A dynamic new assessment for helping victims of trauma to the brain, including those suffering from progressive conditions such as dementia, has been developed by a clinical neuropsychologist at the University of Leicester.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Sonia Rajesh Schneider, MD 4350 Dewey Ave, Omaha, NE 68105-1017 Ph: () - | Sonia Rajesh Schneider, MD 986155 Nebraska Medical Ctr, Omaha, NE 68198-6155 Ph: (402) 559-3964 |
News Archive
NJIT Professor Gordon Thomas and NJIT Research Professor Reginald Farrow, both in the department of physics, and NJIT alumnus Sheng Liu, formerly a doctoral student of both researchers and now an engineer at a biotech company, were awarded a patent today for the NJIT SmartShunt-, a unique device to help patients with brain injuries.
Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the publication of a clinical validation study on the MaterniT GENOME laboratory-developed test in the American Journal of Obstetrics and Gynecology.
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.
Today, Polyphor Ltd published the discovery of a new class of antibiotics with a novel mode of action (Science, VOL 327, ISSUE 5968). This proprietary new class of antibiotics is effective against multi-drug resistant Gram-negative bacteria, opening up new treatment options for serious and often life-threatening infections. The most advanced drug candidate in this new class, POL7080, selectively kills the dangerous bacteria Pseudomonas aeruginosa.
A dynamic new assessment for helping victims of trauma to the brain, including those suffering from progressive conditions such as dementia, has been developed by a clinical neuropsychologist at the University of Leicester.
› Verified 5 days ago
Mr. Stuart Gordon Oxford, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 8309 Cass St, Omaha, NE 68114 Phone: 402-397-8891 Fax: 402-397-8892 | |
Andrew S. Lee, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 14863 Ellison Cir, Omaha, NE 68116 Phone: 402-354-4000 | |
Christopher W. Anderson, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 110 N 175th St Ste 2000, Omaha, NE 68118 Phone: 402-559-8600 Fax: 402-596-4410 | |
Dr. Wesley L. Smeal, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 17021 Lakeside Hills Dr., Ste 200, Omaha, NE 68130 Phone: 847-631-5664 | |
Ms. Angela Pugh, A Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 12020 Pacific St, Omaha, NE 68154 Phone: 800-259-0287 | |
Kristine S. Oleson, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 402-572-2295 | |
Matthew Gregory Hahn, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2725 S 144th St Ste 212, Omaha, NE 68144 Phone: 402-637-0800 Fax: 402-637-0808 |